Alangium salvifolium is a medicinal plant, used by herbalist for treating various diseases, one of which is diabetes mellitus in Central India. However, its antidiabetic activity has not been scientifically validated so far. The aim of the present study was to evaluate the antidiabetic activity of ethanol extracts of leaves and barks of Alangium salvifolium against strepozotocin (STZ)-induced diabetic rats. The ethanol extracts of leaves and barks of Alangium salvifolium at doses of 200 and 400 mg/kg body weight was administered orally to diabetic rats. The blood glucose levels were monitored at specific intervals and found significantly lowered the blood glucose level. Glibenclamide was used as a standard drug at a dose of 0.25 mg/kg. The effect of extracts on induced hyperlipidemia was analyzed where the extracts significantly lowered the elevated total cholesterol, triglycerides (TGL) and low density lipoprotein (LDL) level while increased the high density lipoprotein (HDL). Moreover, the decreased in body weight of rats after induction of diabetes, and increased in body weight of rats after treatment with extracts was observed. The experimental data exhibited that extract of leaves and barks of Alangium salvifolium has significant antidiabetic activity in streptozotocin-induced rats compared to standard drug. The ethanol extracts of leaves exhibited maximum antidiabetic activity as compared to barks extract.
. Alangium salvifolium belongs to genus Alangium, family Alangiaceae. This family consists of twenty-two species out of which Alangium salvifolium is mainly used as medicine in India, China and Phillipines. It is the most versatile medicinal plants having a wide spectrum of biological activity.
Alangium salviifolium showed potent anticancer, diuretic, antiinflammatory, antimicrobial, laxative, astringent, emollient, anthelmintic and antiepileptic activities. The plant was also reported for its anti fungal activity, anti microbial activity, cardiac activity and anti fertility activity [19] [20] [21] [22] . In Ayurveda almost all parts of the tree use for medicinal purposes. The roots and the fruits are used for the treatment of rheumatism, leprosy and hemorrhoid. Externally, it is used for the treatment of bites by rabbits, rats, and dogs. Root bark is an antidote for several poisons. Fruits are sweet, cooling and purgative and used as a poultice for treating burning sensation and haemorrhage 23 . In the present study the antidiabetic activity of leaves and barks of Alangium salvifolium was explored to identify its medicinal properties.
Materials and methods

Plant material
The leaves and barks of Alangium salvifolium were collected from the forest area of Raipur (Chhattisgarh). The plant was authenticated by Taxonomist, Indira Gandhi Krishi Vishwavidyalaya, Raipur, Chhattisgarh, India. A voucher specimen of the plant was preserved in the herbarium for further reference.
Preparation of extracts
500 gram of powdered of leaves and barks were successively extracted on a Soxhlet apparatus, employing petroleum ether, ethanol and distilled water respectively. The solvents of petroleum ether extract, ethanol extract and distilled water extract were removed by distillation and the last traces of solvent being removed under reduced pressure. The ethanol extract of leaves and barks of Alangium salvifolium were used for further pharmacological activity.
The ethanol extract of leaves and barks of Alangium salvifolium were denoted as EASL and EASB respectively.
Acute toxicity study
Limit test at 2000mg/kg body weight was selected to perform acute toxicity study on selected according to the guidelines of the Organization for Economic Cooperation and Development (OECD) 24 .
The purpose of the study was to determine the dose needed to perform different pharmacological activities.
Antidiabetic activity
Oral glucose tolerance test (OGTT) of Alangium salvifolium extract
The oral glucose tolerance test was performed in overnight fasted (18 hours) normal rats. The rats were divided into seven groups (n = 6). Group I served as normal control rats, administered drinking water daily; Group II had glucose control rats; Group III rats were administered standard drug Glibenclamide (0.5 mg/kg); Group IV rats were administered EASL (200 mg/kg); Group V rats were administered EASL (400 mg/kg); Group VI rats were administered EASB (200 mg/kg); and Group VII rats were administered EASB (400 mg/kg). Glucose (2 g/kg) was fed to rats of Group II to Group VII, 30 minutes prior to the administration of the extracts and standard drug. Blood was withdrawn from the retro-orbital sinus after 0, 30, and 90 minutes of extract and standard drug administration, and the plasma obtained after centrifugation at 3000 rpm was estimated for fasting plasma glucose levels using a glucose oxidaseperoxidase glucose estimation kit 25, 27 .
Induction of non-insulin dependent diabetes mellitus (NIDDM)
Non-insulin dependent diabetes mellitus was induced in overnight fasted adult Wistar strain albino male rats weighing 170 -220 g by a single intraperitoneal injection of 60 mg/kg Streptozotocin, 15 minutes after i.p. administration of 120 mg/kg of nicotinamide.
Streptozotocin (STZ) was dissolved in a citrate buffer (pH 4.5) and nicotinamide was dissolved in normal saline. Hyperglycemia was confirmed by the elevated glucose levels in plasma, determined at 72 hours and then on day 7, after injection. The threshold value of fasting plasma glucose to diagnose diabetes was taken as > 126 mg/dl. Only those rats that were found to have permanent NIDDM were used for the study.
Evaluation of antidiabetic activity of Alangium salvifolium extracts
The animals were segregated into seven groups of six rats each.
The extract was administered for 28 days. Group I served as normal control rats, administered drinking water daily for 28 days; Group II had diabetic control rats, administered drinking water daily for 28 days; Group III rats were administered EASL (200 mg/kg); Group IV rats were administered EASL (400 mg/kg); Group V rats were administered EASB (200 mg/kg); Group VI rats were administered EASB (400 mg/kg); and Group VII rats were administered standard drug Glibenclamide (0.5 mg/kg) for 28 days. The fasting glucose levels were determined on days 0, 7 th , 14 th and 28 th of extract administration. During the experimental period, the rats were .
Estimation of biochemical parameters
The biochemical parameters were determined on day 12 after the animals were sacrificed by cervical dislocation. Total cholesterol, triglycerides (TGL), high-density lipoprotein (HDL) and low-density lipoprotein (LDL), were determined by the glucose oxidase method, using an auto-analyzer [29] [30] [31] [32] .
Statistical analysis
The results are expressed as mean ± SEM of six independent experiments. Statistical significance between the groups was evaluated by one-way analysis of variance (ANOVA) followed by Dunet's test. A P < 0.05 value was considered as statistically significant.
Results
Acute toxicity study
Limit test at 2000 mg/kg body weight was selected to perform acute toxicity of ethanol extracts of leaves and barks of Alangium salvifolium on laboratory animals. In LD50 studies, it was found that the animals were safe up to a maximum dose of 2000 mg/kg body weight. There were no changes in normal behavior pattern and no signs and symptoms of toxicity and mortality were observed.
Selection of dose
The LD50 
Oral glucose tolerance effects of Alangium salvifolium
The effects of ethanol extracts of Alangium salvifolium on the plasma glucose level are shown in table 1. After administration of glucose in rats the rise in glucose level was observed in glucose control, extract treated and standard group. In rats treated with leaves and barks extracts of Alangium salvifolium, there was a significant reduction in plasma glucose level, while in glucose control rats the plasma glucose level increased. Meanwhile same results were observed in glibenclamide treated group.
Effect on non-insulin dependent diabetes mellitus of Alangium salvifolium
Induction of diabetes in experimental rats was confirmed by the presence of a high fasting plasma glucose level. The effect of bark and root extracts of Alangium salvifolium, on serum glucose levels of normal and Streptozotocin-induced rats are shown in table 2. 
Anti-hyperlipidaemic activity of Alangium salvifolium
The outcomes of lipid profiles in control and experimental rats are HDL when compared with normal. The rat treated with glibenclamide also reduced TGL, total cholesterol, LDL, and increased HDL when compared with diabetic control group. The EASL and EASB showed significant decrease in total cholesterol, LDL, Triglycerides and significant increase in HDL when compared with diabetic control group. All these effects were observed on day 28. From result of lipid profile it has been observed that the leaves extract exhibited maximum antihyperlipidaemic activity on compared with barks extract. The present experimental result indicated that ethanol extracts of leaves and barks exhibited a potent blood glucose lowering properties in STZ diabetic rats. 
Effect on body weight by Alangium salvifolium
During the study, the body weights of rats before and after induction of diabetes, and after treatment were measured (Table 4 ). The results exhibited that decreased in body weight of rats after induction of diabetes, and increased in body weight of rats after treatment with extracts. 
Discussions
Streptozotocin, a mono functional nitrosourea derivative, derives diabetogenic activity due to its ability to induce oxidative stress and damage in β-cells. Streptozotocin can selectively attack pancreatic β-cells by producing free radicals of oxygen, nitrogen monoxide, and reducing intracellular NAD and NADP, which are crucial for the electron delivery and energy metabolism in β-cells.
The diabetes was induced on rats after administration of streptozotocin. The EASL and EASB were screened for streptozotocin-induced antidiabetic activity. The EASL and EASB significantly reduced the blood glucose level in STZ-induced-diabetic rats as compared to the diabetic control group. Moreover the EASL and EASB increased the body weight of diabetic rats. The possible mechanism by which Alangium salvifolium brings about its hypoglycemic action in diabetic rat may be by potentiating the insulin effect of plasma by increasing either the pancreatic secretion of insulin from the existing beta cells or by its release from the bound form 26, 27 .
Generally, it has been observed that hyperlipidemia is a complication associated with hyperglycemia. During study it was observed increase in total cholesterol, triglycerides, LDL, and decrease in HDL In recent years, considerable interest has been directed towards the investigation of plasma lipids and lipoproteins pattern in diabetes mellitus due to the fact that abnormal lipid level leads to the development of coronary artery disease in diabetic patients.
In the present study, ethanol extract of bark and root of Alangium salvifolium had significantly decreased total cholesterol, triglycerides and LDL with increase in HDL which is having a protective function for the heart compared with diabetic control group [31] [32] [33] .
Conclusions
In present study, we selected Alangium salvifolium to evaluate its antidiabetic activity owing to its traditional uses. The findings of study 
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